| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| filingDate |
2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f343840796827ff7e0a54a8c2c7ee66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c1d16fc717b23163d0f8cc323dca74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c49d03b04126ae5ef670fea7242f5e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5357cca5d92e678284ef9d6aa3e1eebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3b1e2456129d063baef5bffbfa30cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae2ea25730eba8f25cf509d1730c853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecf510cedc22282e81e9f71e228f0de1 |
| publicationDate |
2010-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2218736-A1 |
| titleOfInvention |
Implant coated with multi-domain amphipathic helical peptides and methods of their use |
| abstract |
Disclosed herein are peptides or peptide analogs with multiple amphipathic a-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. Also provided herein are methods of using multi-domain amphipathic a-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein. |
| priorityDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |